Inventor · disambiguated record
Ole Hvilsted Olsen
Also filed as: OLSEN OLE · OLSEN OLE H · OLSEN OLE HVILSTED
42 granted patents·32 pending applications·1,229 citations·filing 1991–2021
98Inventor score
Top patents by PatentIndex Score
74 records- 0197US6410586B1Modulators of protein tyrosine phosphatases (PTPases)NOVO NORDISK AS·Filed 2001·Granted Jun 25, 2002·78 cites·7 claims
- 0296US6262044B1Modulators of protein tyrosine phosphatases (PTPASES)NOVO NORDISK AS·Filed 1999·Granted Jul 17, 2001·108 cites·10 claims
- 0396US5665587AModified subtilisins and detergent compositions containing sameNOVO NORDISK AS·Filed 1995·Granted Sep 9, 1997·146 cites·50 claims
- 0495US6197567B1Modified subtilisins and detergent compositions containing sameNOVO NORDISK AS·Filed 1997·Granted Mar 6, 2001·108 cites·259 claims
- 0594US7026524B2Human coagulation factor VII variantsNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Apr 11, 2006·59 cites·26 claims
- 0692US7416861B2Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2005·Granted Aug 26, 2008·14 cites·7 claims
- 0791US6911323B2Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2003·Granted Jun 28, 2005·31 cites·39 claims
- 0891US6632646B1Modified subtilisins and detergent compositions containing sameNOVOZYMES AS·Filed 2000·Granted Oct 14, 2003·33 cites·87 claims
- 0991US5576294AHuman Kunitz-type protease inhibitor variantNOVO NORDISK AS·Filed 1994·Granted Nov 19, 1996·97 cites·12 claims
- 1090US9370583B2Coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2015·Granted Jun 21, 2016·4 cites·10 claims
- 1190US8361469B2Antibodies against tissue factor pathway inhibitorNOVO NORDISK AS·Filed 2009·Granted Jan 29, 2013·17 cites·4 claims
- 1289US7176288B2Human coagulation factor VII variantsNOVO NORDISK HEALTHCARE AG·Filed 2001·Granted Feb 13, 2007·29 cites·10 claims
- 1389US6960657B2Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted Nov 1, 2005·21 cites·22 claims
- 1488US6905683B2Human coagulation factor VII variantsNOVO NORDISK HEALTHCARE AG·Filed 2001·Granted Jun 14, 2005·15 cites·19 claims
- 1586US5631217ADetergent compositions comprising a modified subtilisinNOVO NORDISK AS·Filed 1995·Granted May 20, 1997·69 cites·48 claims
- 1684US7052868B2Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2002·Granted May 30, 2006·9 cites·45 claims
- 1784US6410556B1Modulators of protein tyrosine phosphateses (PTPases)NOVO NORDISK AS·Filed 2000·Granted Jun 25, 2002·19 cites·77 claims
- 1884US5705482APharmaceutical formulationNOVO NORDISK AS·Filed 1995·Granted Jan 6, 1998·70 cites·12 claims
- 1983US7019026B1Modulators of Protein Tyrosine Phosphatases (PTPases)NOVO NORDISK AS·Filed 2000·Granted Mar 28, 2006·23 cites·74 claims
- 2083US5482849ASubtilisin mutantsNOVO NORDISK AS·Filed 1991·Granted Jan 9, 1996·81 cites·45 claims
- 2182US7416860B2Nucleic acids encoding human coagulation factor VII variantsNOVO NORDISK HELATHCARE A G·Filed 2005·Granted Aug 26, 2008·5 cites·6 claims
- 2280US5618696AHuman kunitz-type protease inhibitor and variants thereofNOVO NORDISK AS·Filed 1995·Granted Apr 8, 1997·35 cites·17 claims
- 2379US5629176AHuman Kunitz-type protease inhibitor variantsNOVO NORDISK AS·Filed 1994·Granted May 13, 1997·39 cites·9 claims
- 2478US9371370B2Coagulation factor VII polypeptidesNOVO NORDISK AS·Filed 2014·Granted Jun 21, 2016·2 cites·15 claims
- 2578US6951878B2Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases)NOVO NORDISK AS·Filed 2002·Granted Oct 4, 2005·7 cites·17 claims
- 2678US6613903B2Modulators of protein tyrosine phosphatases (PTPases)NOVO NORDISK AS·Filed 2001·Granted Sep 2, 2003·9 cites·21 claims
- 2777US5990084ACompounds with growth hormone releasing propertiesNOVO NORDISK AS·Filed 1997·Granted Nov 23, 1999·44 cites·77 claims
- 2875US8513192B2Stable growth hormone compounds resistant to proteolytic degradationOLSEN OLE HVILSTED·Filed 2010·Granted Aug 20, 2013·4 cites·14 claims
- 2974US7115624B1Method of inhibiting protein tyrosine phosphatase 1B and/or T-cell protein tyrosine phosphatase 4 and/or other PTPases with an Asp residue at position 48NOVO NORDISK AS·Filed 2000·Granted Oct 3, 2006·6 cites·6 claims
- 3073US7419803B2Nucleic acids encoding human coagulation Factor VII polypeptidesNOVO NORDISK AS·Filed 2005·Granted Sep 2, 2008·2 cites·15 claims
- 3172US2022073895A1Human coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2021·Application pending·0 cites
- 3267US9493543B2Factor VIII fusion proteinBOLT GERT·Filed 2011·Granted Nov 15, 2016·2 cites·19 claims
- 3366US7189553B2Modified subtilisins and detergent, compositions containing sameNOVOZYMES AS·Filed 2002·Granted Mar 13, 2007·5 cites·7 claims
- 3464US2008318276A1Human Coagulation Factor VII VariantsNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 3564US2009104661A1Human Coagulation Factor VII PolypeptidesNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 3663US2018142227A1Coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2018·Application pending·0 cites
- 3762US10906960B2Factor VIII variants having a decreased cellular uptakeNOVO NORDISK AS·Filed 2018·Granted Feb 2, 2021·0 cites·5 claims
- 3862US2020010820A1Human coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2019·Application pending·0 cites
- 3962US2019211112A1Antibodies Against Tissue Factor Pathway InhibitorNOVO NORDISK AS·Filed 2019·Application pending·0 cites
- 4060US9574011B2Antibodies against tissue factor pathway inhibitorNOVO NORDISK AS·Filed 2012·Granted Feb 21, 2017·0 cites·13 claims
- 4160US7695935B2Nucleic acids encoding human coagulation FVII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2006·Granted Apr 13, 2010·0 cites·11 claims
- 4260US2010303786A1Stabilisation of Liquid-Formulated Factor VII(A) Polypeptides by Aldehyde-Containing CompoundsNOVO NORDISK HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 4359US8652471B2Methods of treating coagulopathies using antibodies against tissue factor pathway inhibitorNOVO NORDISK AS·Filed 2012·Granted Feb 18, 2014·0 cites·19 claims
- 4459US2008010693A1Human coagulation factor VII polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 4559US2017096655A1Coagulation factor vii polypeptidesNOVO NORDISK HEALTHCARE AG·Filed 2016·Application pending·0 cites
- 4657US9125890B2Compounds suitable for treatment of haemophiliaNOVO NORDISK AS·Filed 2013·Granted Sep 8, 2015·0 cites·20 claims
- 4756US10047142B2Factor VIII variants having a decreased cellular uptakeNOVO NORDISK AS·Filed 2016·Granted Aug 14, 2018·0 cites·6 claims
- 4856US2016002314A1Factor viii variants having a decreased cellular uptakeNOVO NORDISK AS·Filed 2015·Application pending·0 cites
- 4956US2010158891A1Human Coagulation Factor VII VariantsNOVO NORDISK HEALTHCARE AG·Filed 2010·Application pending·0 cites
- 5056US2017114147A1Antibodies Against Tissue Factor Pathway InhibitorNOVO NORDISK AS·Filed 2017·Application pending·0 cites
Showing the top 50 of 74 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →